Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-'The best shield': Peru launches inoculation drive with Sinopharm vaccine

Wed, 10th Feb 2021 01:13

(Adds comment from Peru's president)

By Marco Aquino

LIMA, Feb 9 (Reuters) - Peru launched its COVID-19
vaccination campaign on Tuesday with newly arrived doses of
China's Sinopharm vaccine, as the South American
country struggles to control a fierce second wave of infections
that has forced a lockdown in the capital, Lima.

Health officials kicked off the program in the intensive
care unit of Lima's Arzobispo Loayza Hospital, authorities said,
where medical staff were slated to receive the first of 300,000
doses delivered on Sunday by Sinopharm Group Co Ltd.

Peruvian President Francisco Sagasti was vaccinated later in
the day and urged vaccine skeptics to get inoculated. A survey
by Ipsos Peru last month showed 48% of Peruvians would refuse to
be vaccinated, citing fears of side effects.

"Do not be afraid of the vaccine. The vaccine is the best
shield," Sagasti said in a brief speech shortly before receiving
his shot at a military hospital.

"We are betting as much as possible that all Peruvians can
be vaccinated this year," he added.

Coronavirus infections have spiked in Peru this year,
bringing hospitals and the country's ailing healthcare system to
the brink of collapse. Authorities have detected both the
Brazilian and British variants of the virus, officials said.

Peru, which was mired in a political crisis last year,
initially lagged behind its wealthier neighbors in locking down
COVID-19 vaccine deals.

The Andean nation has since signed agreements with
U.S.-based Pfizer Inc, British-Swedish firm AstraZeneca
and Sinopharm, and is also slated to receive vaccines
through the World Health Organization's COVAX program.

The country plans to begin immediately inoculating a
million health officials, police and military personnel, among
others, the government said, in a first round of vaccinations
that will likely run through March.

Peru will then vaccinate 5.3 million elderly people, those
suffering from pre-existing conditions and its native
communities.

Peru's deal with Sinopharm guarantees the country 38 million
doses. A fresh batch of 700,000 doses is expected to arrive on
Sunday, health officials said.

Peru has tallied almost 1.2 million cases of COVID-19 and
42,400 deaths.
(Reporting by Marco Aquino and Reuters TV; Writing by Dave
Sherwood; Editing by Paul Simao and Peter Cooney)

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.